- Report
- July 2025
- 350 Pages
Global
From €4383EUR$4,949USD£3,787GBP
- Report
- August 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,711GBP
- Report
- November 2025
- 150 Pages
Global
From €5269EUR$5,950USD£4,553GBP
- Report
- July 2025
- 120 Pages
Global
From €5269EUR$5,950USD£4,553GBP
- Report
- February 2026
- 250 Pages
Global
From €3976EUR$4,490USD£3,436GBP
- Report
- May 2026
- 487 Pages
Global
From €5181EUR$5,850USD£4,477GBP
- Report
- May 2026
- 563 Pages
Global
From €5181EUR$5,850USD£4,477GBP
- Report
- November 2025
- 185 Pages
Global
From €3985EUR$4,500USD£3,444GBP
- Report
- June 2025
- 400 Pages
Global
From €4383EUR$4,949USD£3,787GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2470EUR$2,789USD£2,134GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2470EUR$2,789USD£2,134GBP
- Report
- March 2026
- 135 Pages
Global
From €4295EUR$4,850USD£3,711GBP
- Report
- November 2025
- 150 Pages
United States
From €3498EUR$3,950USD£3,023GBP
- Report
- February 2026
- 250 Pages
Global
From €3976EUR$4,490USD£3,436GBP
- Report
- June 2024
- 200 Pages
Global
From €7040EUR$7,950USD£6,084GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1328EUR$1,500USD£1,148GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1771EUR$2,000USD£1,530GBP
- Report
- June 2024
- 200 Pages
Global
From €7040EUR$7,950USD£6,084GBP
- Report
- January 2022
- 60 Pages
Global
From €3498EUR$3,950USD£3,023GBP
- Report
- May 2024
- 137 Pages
Global
From €3541EUR$3,999USD£3,060GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more